Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O T Brustugun

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
British Journal of Cancer|July 2, 2014
Years of life lost as a measure of cancer burden on a national levelO T Brustugun, B Møller, A Helland
Acta Oncologica (Stockholm, Sweden)|November 29, 2016
Real-world data on nivolumab treatment of non-small cell lung cancerO T Brustugun, M Sprauten, Å Helland
Experimental Cell Research|August 1, 1995
Sensitive and rapid detection of beta-galactosidase expression in intact cells by microinjection of fluorescent substrateO T Brustugun, G Mellgren, B T Gjertsen, et al.
Bioorganic & Medicinal Chemistry Letters|March 31, 2000
Membrane-permeant, bioactivatable analogues of cGMP as inducers of cell death in IPC-81 leukemia cellsF Schwede, O T Brustugun, M Zorn-Kruppa, et al.
Cell Death and Differentiation|April 14, 1999
Apoptosis induced by microinjection of cytochrome c is caspase-dependent and is inhibited by Bcl-2O T Brustugun, K E Fladmark, S O Doskeland, et al.
ESMO Open|April 30, 2025
Real-world comparison of pembrolizumab alone and combined with chemotherapy in metastatic lung adenocarcinoma patients with PD-L1 expression ≥50H H Hektoen, K M Tsuruda, O T Brustugun, et al.
Endocrinology|June 1, 1995
Cyclic adenosine monophosphate (cAMP) analogs 8-Cl- and 8-NH2-cAMP induce cell death independently of cAMP kinase-mediated inhibition of the G1/S transition in mammary carcinoma cells (MCF-7)O K Vintermyr, R Bøe, O T Brustugun, et al.
Cell Death and Differentiation|December 1, 1999
Ultrarapid caspase-3 dependent apoptosis induction by serine/threonine phosphatase inhibitorsK E Fladmark, O T Brustugun, R Hovland, et al.
Leukemia|November 1, 1995
Effects of interleukin 10 on blast cells derived from patients with acute myelogenous leukemiaO Bruserud, B Tore Gjertsen, O T Brustugun, et al.
British Journal of Cancer|August 15, 2013
Clinical significance of disseminated tumour cells in non-small cell lung cancerAne Kongsgaard, E Borgen, G M Mælandsmo, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
British Journal of Cancer|July 2, 2014
Years of life lost as a measure of cancer burden on a national levelO T Brustugun, B Møller, A Helland
Acta Oncologica (Stockholm, Sweden)|November 29, 2016
Real-world data on nivolumab treatment of non-small cell lung cancerO T Brustugun, M Sprauten, Å Helland
Experimental Cell Research|August 1, 1995
Sensitive and rapid detection of beta-galactosidase expression in intact cells by microinjection of fluorescent substrateO T Brustugun, G Mellgren, B T Gjertsen, et al.
Bioorganic & Medicinal Chemistry Letters|March 31, 2000
Membrane-permeant, bioactivatable analogues of cGMP as inducers of cell death in IPC-81 leukemia cellsF Schwede, O T Brustugun, M Zorn-Kruppa, et al.
Cell Death and Differentiation|April 14, 1999
Apoptosis induced by microinjection of cytochrome c is caspase-dependent and is inhibited by Bcl-2O T Brustugun, K E Fladmark, S O Doskeland, et al.
ESMO Open|April 30, 2025
Real-world comparison of pembrolizumab alone and combined with chemotherapy in metastatic lung adenocarcinoma patients with PD-L1 expression ≥50H H Hektoen, K M Tsuruda, O T Brustugun, et al.
Endocrinology|June 1, 1995
Cyclic adenosine monophosphate (cAMP) analogs 8-Cl- and 8-NH2-cAMP induce cell death independently of cAMP kinase-mediated inhibition of the G1/S transition in mammary carcinoma cells (MCF-7)O K Vintermyr, R Bøe, O T Brustugun, et al.
Cell Death and Differentiation|December 1, 1999
Ultrarapid caspase-3 dependent apoptosis induction by serine/threonine phosphatase inhibitorsK E Fladmark, O T Brustugun, R Hovland, et al.
Leukemia|November 1, 1995
Effects of interleukin 10 on blast cells derived from patients with acute myelogenous leukemiaO Bruserud, B Tore Gjertsen, O T Brustugun, et al.
British Journal of Cancer|August 15, 2013
Clinical significance of disseminated tumour cells in non-small cell lung cancerAne Kongsgaard, E Borgen, G M Mælandsmo, et al.
Pageof 2